The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Open accessAbstract
Inappropriate polypharmacy, especially in older people, imposes a substantial burden of adverse drug events, ill health, disability, hospitalization, and even death. The single most important predictor of inappropriate prescribing and risk of adverse drug events in older patients is the number of prescribed drugs. Deprescribing is the process of tapering or stopping drugs, aimed at minimizing polypharmacy and improving patient outcomes. Evidence of efficacy for deprescribing is emerging from randomized trials and observational studies. A deprescribing protocol is proposed comprising 5 steps: (1) ascertain all drugs the patient is currently taking and the reasons for each one; (2) consider overall risk of drug-induced harm in individual patients in determining the required intensity of deprescribing intervention; (3) assess each drug in regard to its current or future benefit potential compared with current or future harm or burden potential; (4) prioritize drugs for discontinuation that have the lowest benefit-harm ratio and lowest likelihood of adverse withdrawal reactions or disease rebound syndromes; and (5) implement a discontinuation regimen and monitor patients closely for improvement in outcomes or onset of adverse effects. Whereas patient and prescriber barriers to deprescribing exist, resources and strategies are available that facilitate deliberate yet judicious deprescribing and deserve wider application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
Emergency Hospitalizations for Adverse Drug Events in Older Americans
Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1103053 · Cited by 1,820
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
Self-citationInterventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Anderson, K., Stowasser, D., Freeman, C., & Scott, I. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-006544 · Cited by 725
Self-citationTannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665
Hamilton, H., Gallagher, P., Ryan, C., Byrne, S., & O’Mahony, D. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.215 · Cited by 566
Patient Barriers to and Enablers of Deprescribing: a Systematic Review
Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0106-8 · Cited by 536
Self-citation
Cited by
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Hypertension Management in Older and Frail Older Patients
Benetos, A., Petrovic, M., & Strandberg, T. (2019) · Circulation Research · doi:10.1161/circresaha.118.313236 · Cited by 508
Page, A. T., Clifford, R. M., Potter, K., Schwartz, D., & Etherton‐Beer, C. D. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12975 · Cited by 496
Self-citationMartin, P., Tamblyn, R., Benedetti, A., Ahmed, S., & Tannenbaum, C. (2018) · JAMA · doi:10.1001/jama.2018.16131 · Cited by 401
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M.-L., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 376
Reeve, E., Thompson, W., & Farrell, B. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.12.021 · Cited by 331
Self-citationPolypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes
Lipska, K. J., Krumholz, H., Soones, T., & Lee, S. J. (2016) · JAMA · doi:10.1001/jama.2016.0299 · Cited by 309
Too much medicine in older people? Deprescribing through shared decision making
Jansen, J., Naganathan, V., Carter, S. M., McLachlan, A. J., Nickel, B., Irwig, L., Bonner, C., Doust, J., Colvin, J., Heaney, A., et al. (2016) · BMJ · doi:10.1136/bmj.i2893 · Cited by 303
Self-citationAppropriate Polypharmacy and Medicine Safety: When Many is not Too Many
Cadogan, C. A., Ryan, C., & Hughes, C. M. (2016) · Drug Safety · doi:10.1007/s40264-015-0378-5 · Cited by 298
Adverse drug reactions in older adults: a narrative review of the literature
Zazzara, M. B., Palmer, K., Vetrano, D. L., Carfì, A., & Onder, G. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00481-9 · Cited by 283
Tinetti, M. E., Naik, A. D., Dindo, L., Costello, D. M., Esterson, J., Geda, M., Rosen, J., Hernandez-Bigos, K., Smith, C. D., Ouellet, G. M., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4235 · Cited by 282
Kua, C.-H., Mak, V. S. L., & Huey Lee, S. W. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.10.026 · Cited by 271
Polypharmacy and Medication Management in Older Adults
Kim, J., & Parish, A. L. (2017) · Nursing Clinics of North America · doi:10.1016/j.cnur.2017.04.007 · Cited by 245
Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis
Bloomfield, H. E., Greer, N., Linsky, A. M., Bolduc, J., Naidl, T., Vardeny, O., MacDonald, R., McKenzie, L., & Wilt, T. J. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06089-2 · Cited by 240
Farrell, B., Pottie, K., Rojas-Fernandez, C. H., Bjerre, L. M., Thompson, W., & Welch, V. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161248 · Cited by 134
Gao, L., Maidment, I., Matthews, F. E., Robinson, L., Brayne, C., & on behalf of the Medical Research Council Cognitive Function and Ageing Study (2018) · Age and Ageing · doi:10.1093/ageing/afx158 · Cited by 123
Scott, I. A., Pillans, P. I., Barras, M., & Morris, C. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618784809 · Cited by 114
Self-citationSeidu, S., Kunutsor, S. K., Topsever, P., Hambling, C. E., Cos, F. X., & Khunti, K. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13724 · Cited by 97
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Assessing medication burden and polypharmacy: finding the perfect measure
Gnjidic, D., Tinetti, M., & Allore, H. G. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1301206 · Cited by 54
Self-citationHoulind, M. B., Andersen, A. L., Treldal, C., Jørgensen, L. M., Kannegaard, P. N., Castillo, L. S., Christensen, L. D., Tavenier, J., Rasmussen, L. J. H., Ankarfeldt, M. Z., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020348 · Cited by 48
“Therefore, dose reduction and discontinuation of inappropriate medication (deprescribing) is an important focus of medication reviews in older patients [13].”
BackgroundUse and discontinuation of insulin treatment among adults aged 75 to 79 years with type 2 diabetes
Weiner, J. Z., Gopalan, A., Mishra, P., Lipska, K. J., Huang, E. S., Laiteerapong, N., Karter, A. J., & Grant, R. W. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3759 · Cited by 47
Rasmussen, A. F., Poulsen, S. S., Oldenburg, L. I. K., & Vermehren, C. (2021) · Metabolites · doi:10.3390/metabo11040254 · Cited by 39
Kuntz, J. L., Kouch, L., Christian, D., Hu, W., & Peterson, P. L. (2019) · The Permanente Journal · doi:10.7812/tpp/18-161 · Cited by 43
Deprescribing antipsychotics: a guide for clinicians
Gupta, S., Cahill, J. D., & Miller, R. (2018) · BJPsych Advances · doi:10.1192/bja.2018.2 · Cited by 35
Socrates, V., Wright, D. S., Huang, T., Fereydooni, S., Dien, C., Chi, L., Albano, J., Patterson, B., Sasidhar Kanaparthy, N., Wright, C. X., et al. (2025) · JMIR Aging · doi:10.2196/69504 · Cited by 17
Diabetes Deprescribing in Older Adults: A Randomized Clinical Trial
Grant, R. W., Peterson, I., McCloskey, J. M., Lipska, K. J., Nugent, J., Karter, A. J., & Gilliam, L. K. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.2015 · Cited by 11
Weir, K. R., Jungo, K. T., & Streit, S. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15966 · Cited by 9
Metadata
- Authors
- Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., Jansen, J., & Martin, J. H.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2015-05-01
- Volume
- 175
- Issue
- 5
- Pages
- 827
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2153054970
- Cited by
- 1,584
- References
- 52
- FWCI
- 53.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.